This medicines update is provided by the Veterinary Medicines Directorate (VMD) and lists new active substance, new marketing authorisations and changes to authorisations most relevant to vets. Changes to authorisations most relevant to vets The changes to authorisations most relevant to vets can be found below. Each product listed, along with the authorisation holder, distribution category and details of which Summary of Product Characteristics sections have been revised/changed. All entries ca

Following a recent poll, the VMD has refreshed the information provided in the monthly medicines update, please send any comments or feedback to postmaster@vmd.gov.uk. New marketing authorisations: See the VMD’s Product Information Database for more information. The authorisation territories, GB or NI, are links to their entry in the VMD’s Product Information Database. There may be a delay between the issuing of a Marketing Authorisation and the product being placed on the market. New Marketing

The pharmacovigilance team at the Veterinary Medicines Directorate (VMD) monitors adverse event reports for veterinary medicines authorised in the UK. We receive adverse event reports from vets, animal owners and Marketing Authorisation Holders (MAH). We have received lack of efficacy reports concerning the use of the euthanasia product - Somulose Solution for Injection (secobarbital and cinchocaine). We would therefore like to remind vets about the information contained in the Summary of Produc